FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/03/051010 [Registered on: 23/03/2023] Trial Registered Prospectively
Last Modified On: 23/03/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   study the relationship between an ovarian reserve hormone and the number of eggs retrieved in an IVF cycle 
Scientific Title of Study   to study the serum AMH correlation with number of oocytes retrieved in controlled ovarian stimulation in Indian women ≤ 35 years: managing patients expectations 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR K D NAYAR  
Designation  CHAIRPERSON , AKANKSHA IVF 
Affiliation  AKANKSHA IVF 
Address  AKANKSHA IVF , ROOM NUMBER 628 ,NEW BUILDING , MATA CHANAN DEVI HOSPITAL, BLOCK C1 , JANAKPURI

West
DELHI
110058
India 
Phone  45582000  
Fax    
Email  kdnayar@usa.net  
 
Details of Contact Person
Scientific Query
 
Name  sakshi nayar 
Designation  FELLOWSHIP STUDENT  
Affiliation  AKANKSHA IVF 
Address  AKANKSHA IVF , ROOM NUMBER 628 , NEW BUILDING , MATA CHANAN DEVI HOSPITAL, BLOCK C1 , JANAKPURI

West
DELHI
110058
India 
Phone  9811181718  
Fax    
Email  sakshimiglani11@gmail.com  
 
Details of Contact Person
Public Query
 
Name  sakshi nayar 
Designation  FELLOWSHIP STUDENT  
Affiliation  AKANKSHA IVF 
Address  AKANKSHA IVF , ROOM NUMBER 628 , NEW BUILDING MATA CHANAN DEVI HOSPITAL, BLOCK C1 , JANAKPURI

West
DELHI
110058
India 
Phone  9811181718  
Fax    
Email  sakshimiglani11@gmail.com  
 
Source of Monetary or Material Support  
AKANKSHA IVF CENTRE , ROOM NUMBER 628 , NEW BUILDING , MATA CHANAN DEVI HOSPITAL , C1 BLOCK , JANAKPURI  
 
Primary Sponsor  
Name  DR K D NAYAR 
Address  AKANKSHA IVF , ROOM NUMBER 628, NEW BUILDING , MATA CHANAN DEVI HOSPITAL , BLOCK C1, JANAKPURI 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SAKSHI NAYAR  AKANKSHA IVF CENTER   ROOM NUMBER 628 , NEW BUILDING, MATA CHANAN DEVI HOSPITAL , BLOCK C1, JANAKPURI
West
DELHI 
9811181718

sakshimiglani11@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INDEPENDENT ETHICAL COMMITTEE OF IFS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N971||Female infertility of tubal origin, (2) ICD-10 Condition: N972||Female infertility of uterine origin, (3) ICD-10 Condition: N979||Female infertility, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  23.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  HEALTHY INDIAN FEMALES 
 
ExclusionCriteria 
Details  > 35 YEARS
PREVIOUS IVF CYCLES
PREVIOUS OVARIAN SURGERY / OVARIAN PATHOLOGY
CO-EXISTING MEDICAL CONDITION 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
IN AN CONTROLLED OVARIAN STIMULATION CYCLE IN A PATIENT UNDERGOING IVF , NUMBER OF OOCYTES RETRIEVED IS CORRELATED TO THE SERUM AMH OF THE PATIENT

 
10 TO 15 DAYS OF STIMULATION
 
 
Secondary Outcome  
Outcome  TimePoints 
CO-RELATION OF NUMBER OF OOCYTES WITH SERUM AMH AND CLINICAL PREGNANCY RATE
CUT OFF VALUE OF SERUM AMH TO DETERMINE POOR OVARIAN RESPONDER AND HYPER -RESPONDER 
6 MONTHS 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   SERUM AMH IS ONE OF THE MARKERS TO DETERMINE OVARIAN RESERVE . OTHER PROMINENT MARKERS BEING ANTRAL FOLLICLE COUNT (AFC) AND FSH . IF WE CAN DETERMINE THE COR-RELATON BETWEEN THE VALUE OF SERUM AMH WITH THE NUMBER OF OOCYTES RETRIEVED IN AN INDIAN WOMEN AFTER CONTROLLED OVARIAN STIMULATION , IT WILL HELP IN BETTER COUNSELING AND MANAGING PATIENT’S EXPECTATIONS. SO FAR, TO THE BEST OF MY KNOWLEDGE THERE IS ONLY ONE INDIAN STUDY WHICH HAS LOOKED AT THE SERUM AMH AND THE NUMBER OF OOCYTES RETRIEVED. 
Close